Literature DB >> 613292

The pathology of Rift Valley fever. I. Lesions occurring in natural cases in new-born lambs.

J A Coetzer.   

Abstract

A widespread epizootic of Rift Valley fever occurred in the Republic of South Africa and South West Africa during 1974--75. This is a report on the gross pathology of 34 new-born lambs and the histopathology of 93 new-born lambs that died during this outbreak. The liver was affected in every case and showed the most pronounced lesions. The organ was grossly enlarged in most cases, with scattered greyish-white necrotic foci 1--2 mm in diameter and haemorrhages of varying size throughout. Haemorrhages were also frequently seen in the mucosa of the abomasum. The massive diffuse necrosis of hepatocytes (pannecrosis) associated with well-demarcated foci of primary coagulative necrosis, present in 100% of the cases examined, was characteristic of the histopathology of the new-born lamb. Bile thrombi were noticed in the livers of 31% of the lambs and intranuclear inclusions in 49% of the cases. The diagnostic significance of the microscopic liver lesions is discussed. Focal necrosis and haemorrhages were frequently seen in the adrenal cortex while generalized destruction of lymphocytes in the lymph nodes and spleen occurred in many of the animals. In addition, the following hitherto undescribed or previously not well-documented lesions are recorded: (i) mineralization of single or groups of necrotic hepatocytes in 62% of the livers: (ii) pyknosis and karyorrhexis of the cellular elements in the glomeruli and a hyalinized appearance of many of these affected glomeruli; and (iii) necrosis of the tips of the villi in the small intestine in some of the animals.

Entities:  

Mesh:

Year:  1977        PMID: 613292

Source DB:  PubMed          Journal:  Onderstepoort J Vet Res        ISSN: 0030-2465            Impact factor:   1.792


  28 in total

1.  Creation of a nonspreading Rift Valley fever virus.

Authors:  Jeroen Kortekaas; Nadia Oreshkova; Viviana Cobos-Jiménez; Rianka P M Vloet; Christiaan A Potgieter; Rob J M Moormann
Journal:  J Virol       Date:  2011-09-28       Impact factor: 5.103

2.  Inhibition of Rift Valley fever virus replication and perturbation of nucleocapsid-RNA interactions by suramin.

Authors:  Mary Ellenbecker; Jean-Marc Lanchy; J Stephen Lodmell
Journal:  Antimicrob Agents Chemother       Date:  2014-09-29       Impact factor: 5.191

3.  Recombinant Rift Valley fever vaccines induce protective levels of antibody in baboons and resistance to lethal challenge in mice.

Authors:  James F Papin; Paulo H Verardi; Leslie A Jones; Francisco Monge-Navarro; Aaron C Brault; Michael R Holbrook; Melissa N Worthy; Alexander N Freiberg; Tilahun D Yilma
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-23       Impact factor: 11.205

4.  Pathologic studies on suspect animal and human cases of Rift Valley fever from an outbreak in Eastern Africa, 2006-2007.

Authors:  Wun-Ju Shieh; Chris D Paddock; Edith Lederman; Carol Y Rao; L Hannah Gould; Mohamed Mohamed; Fausta Mosha; Janeth Mghamba; Peter Bloland; M Kariuki Njenga; David Mutonga; Amwayi A Samuel; Jeannette Guarner; Robert F Breiman; Sherif R Zaki
Journal:  Am J Trop Med Hyg       Date:  2010-08       Impact factor: 2.345

5.  Pathogenesis of a phleboviral infection (Punta Toro virus) in golden Syrian hamsters.

Authors:  G W Anderson; M V Slayter; W Hall; C J Peters
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

6.  Rift Valley fever virus vaccine lacking the NSs and NSm genes is safe, nonteratogenic, and confers protection from viremia, pyrexia, and abortion following challenge in adult and pregnant sheep.

Authors:  Brian H Bird; Louis H Maartens; Shelley Campbell; Baltus J Erasmus; Bobbie R Erickson; Kimberly A Dodd; Christina F Spiropoulou; Deborah Cannon; Clifton P Drew; Barbara Knust; Anita K McElroy; Marina L Khristova; César G Albariño; Stuart T Nichol
Journal:  J Virol       Date:  2011-10-05       Impact factor: 5.103

7.  Rift Valley fever virus(Bunyaviridae: Phlebovirus): an update on pathogenesis, molecular epidemiology, vectors, diagnostics and prevention.

Authors:  Michel Pepin; Michele Bouloy; Brian H Bird; Alan Kemp; Janusz Paweska
Journal:  Vet Res       Date:  2010 Nov-Dec       Impact factor: 3.683

8.  Highly sensitive and broadly reactive quantitative reverse transcription-PCR assay for high-throughput detection of Rift Valley fever virus.

Authors:  Brian H Bird; Darcy A Bawiec; Thomas G Ksiazek; Trevor R Shoemaker; Stuart T Nichol
Journal:  J Clin Microbiol       Date:  2007-09-05       Impact factor: 5.948

9.  IFITM-2 and IFITM-3 but not IFITM-1 restrict Rift Valley fever virus.

Authors:  Rajini Mudhasani; Julie P Tran; Cary Retterer; Sheli R Radoshitzky; Krishna P Kota; Louis A Altamura; Jeffrey M Smith; Beverly Z Packard; Jens H Kuhn; Julie Costantino; Aura R Garrison; Connie S Schmaljohn; I-Chueh Huang; Michael Farzan; Sina Bavari
Journal:  J Virol       Date:  2013-05-29       Impact factor: 5.103

10.  Pathological studies on postvaccinal reactions of Rift Valley fever in goats.

Authors:  Samia Ahmed Kamal
Journal:  Virol J       Date:  2009-07-06       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.